BlackRock Portfolio holdings
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Palantir
PLTR
|
+$926M |
| 2 |
Sea Limited
SE
|
+$712M |
| 3 |
iShares Core MSCI Total International Stock ETF
IXUS
|
+$697M |
| 4 |
Wells Fargo
WFC
|
+$687M |
| 5 |
Blackstone
BX
|
+$652M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$16.4B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.4B |
| 3 |
Apple
AAPL
|
+$3.41B |
| 4 |
Microsoft
MSFT
|
+$3.3B |
| 5 |
Linde
LIN
|
+$2.07B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.52% |
| 2 | Healthcare | 13.51% |
| 3 | Financials | 13.07% |
| 4 | Consumer Discretionary | 11.27% |
| 5 | Communication Services | 8.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MCBC
3401
DELISTED
Macatawa Bank Corp
MCBC
| $16.4M | ﹤0.01% |
1,868,940
+44,198
| +2% | +$422K |
|
3402
Vanguard Morningstar Value ETF
VTV
$189B
| $16.3M | ﹤0.01% |
118,905
+3,944
| +3% | +$542K |
|
3403
Full House Resorts
FLL
$82.3M
| $16.3M | ﹤0.01% |
1,641,653
+1,563,926
| +2,012% | +$15.1M |
|
3404
FS KKR Capital
FSK
$3.16B
| $16.3M | ﹤0.01% |
757,883
+85,199
| +13% | +$1.82M |
|
|
BELFB
3405
Bel Fuse Inc Class B
BELFB
$4.19B
| $16.3M | ﹤0.01% |
1,130,087
-554,927
| -33% | -$9.13M |
|
3406
Aviat Networks
AVNW
$278M
| $16.2M | ﹤0.01% |
494,026
+297,434
| +151% | +$10.4M |
|
3407
LiveOne
LVO
$61.7M
| $16.2M | ﹤0.01% |
342,217
-7,323
| -2% | -$318K |
|
|
XIFR
3408
XPLR Infrastructure LP
XIFR
$1.11B
| $16.2M | ﹤0.01% |
211,502
-614
| -0.3% | -$43.9K |
|
3409
Instil Bio
TIL
$49M
| $16.1M | ﹤0.01% |
41,767
+40,267
| +2,684% | +$14.9M |
|
|
CMAX
3410
DELISTED
CareMax, Inc. Class A Common Stock
CMAX
| $16.1M | ﹤0.01% |
41,519
-148
| -0.4% | -$58.8K |
|
3411
iShares MSCI Intl Value Factor ETF
IVLU
$4.48B
| $16.1M | ﹤0.01% |
622,119
-50,633
| -8% | -$1.33M |
|
3412
Suncor Energy
SU
$76.1B
| $15.9M | ﹤0.01% |
662,370
+17,704
| +3% | +$406K |
|
3413
Viemed Healthcare
VMD
$367M
| $15.9M | ﹤0.01% |
2,218,689
+5,475
| +0.2% | +$47.4K |
|
3414
Manulife Financial
MFC
$74B
| $15.8M | ﹤0.01% |
804,188
+7,344
| +0.9% | +$154K |
|
3415
iShares North American Natural Resources ETF
IGE
$744M
| $15.8M | ﹤0.01% |
519,778
| – | – |
|
3416
FS Bancorp
FSBW
$316M
| $15.8M | ﹤0.01% |
443,618
-17,334
| -4% | -$600K |
|
|
RTPZ.U
3417
DELISTED
Reinvent Technology Partners Z Units, each consisting of one Class A ordinary share and one-fifth o
RTPZ.U
| $15.8M | ﹤0.01% |
1,534,290
-6,091
| -0.4% | -$62.7K |
|
3418
DarioHealth
DRIO
$69.2M
| $15.7M | ﹤0.01% |
36,811
+36,755
| +65,634% | +$14M |
|
|
ORAN
3419
DELISTED
Orange
ORAN
| $15.7M | ﹤0.01% |
1,373,193
+301,748
| +28% | +$3.77M |
|
3420
Blue Ridge Bankshares
BRBS
$325M
| $15.7M | ﹤0.01% |
896,426
+859,632
| +2,336% | +$14.1M |
|
3421
Cardiff Oncology
CRDF
$71.8M
| $15.7M | ﹤0.01% |
2,359,983
+1,823,225
| +340% | +$15.5M |
|
|
DBTX
3422
DELISTED
Decibel Therapeutics, Inc. Common Stock
DBTX
| $15.7M | ﹤0.01% |
1,824,310
-332,494
| -15% | -$2.93M |
|
3423
Byrna Technologies
BYRN
$112M
| $15.7M | ﹤0.01% |
+689,851
| New | +$17M |
|
|
NTCO
3424
DELISTED
Natura &Co Holding S.A. American Depositary Shares (each representing two Common Shares)
NTCO
| $15.6M | ﹤0.01% |
687,566
+86,358
| +14% | +$1.7M |
|
3425
Golub Capital BDC
GBDC
$3.42B
| $15.6M | ﹤0.01% |
1,008,435
+90,365
| +10% | +$1.4M |
|
Similar funds
BlackRock's Q2 2021 Portfolio in Review
As of Q2 2021, BlackRock held 5,668 positions worth $3.59T, up 5.6% from $3.4T the previous quarter. Its ten largest holdings account for 18% of the portfolio.
BlackRock's Q2 2021 filing shows 333 new, 2,001 increased, 2,748 reduced and 150 closed positions. Its largest new stake was Organon & Co: 16,503,495 shares worth $499M. The largest sale was Alibaba, an estimated $16.4B.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.
- BlackRock's largest Q2 2021 buy was Organon & Co: 16,503,495 shares worth $499M.
- BlackRock added most to Palantir in Q2 2021, an estimated $926M increase.
- BlackRock's biggest Q2 2021 reduction was Alibaba, cutting an estimated $16.4B.
- BlackRock fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $1.35B.
- BlackRock's ten largest holdings make up 18% of its $3.59T portfolio in Q2 2021.
- BlackRock opened 333 new positions and closed 150 in Q2 2021.
- BlackRock's portfolio value rose 5.6% quarter-over-quarter to $3.59T.
Based on BlackRock's 13F filing for Q2 2021, filed 11 Aug 2021.